KAApA Biotech

KAApA Biotech produces premium functional mushroom extracts using its proprietary NordRelease extraction technology, delivering standardized bioactive profiles for nutraceutical and functional food applications. The company's portfolio includes extracts of Lion's Mane, Chaga, Reishi, Cordyceps, Maitake, Shiitake, and Turkey Tail, each developed with controlled extraction parameters that preserve key bioactive compounds while ensuring batch-to-batch consistency. NordRelease extracts are scientifically supported, clinically evaluated, and designed to deliver the lowest cost per effective dose in finished formulations. The company maintains full traceability from cultivation to final extract, with organic certification, FSSC 22000 food safety certification, EU EFSA approval for its extraction process, and Certificates of Analysis available per batch. KAApA operates from its headquarters and production facility in Karjalohja, Finland, and serves over 150 partners worldwide. The company won the NutraIngredients Awards Start-up Award in 2021. Founded in 2018, the company has raised approximately $14.1 million at the seed stage, backed by PeakBridge VC and Zintinus VC.